Topical Chinese medicine preparation for treatment of mammary breast gland lobular hyperplasia

Abstract

The invention discloses a topical Chinese medicine preparation for treatment of mammary breast gland lobular hyperplasia. The topical Chinese medicine preparation is prepared from the following compositions in parts by weight: 20-40 parts of semen citri reticulatae, 10-30 parts of thunberg fritillary bulb, 10-30 parts of radix scrophulariae, 20-40 parts of concha ostreae, 8-16 parts of olibanum, 8-16 parts of myrrh, 5-15 parts of corydalis yanhusuo, 4-8 parts of cinnamon, 8-16 parts of bile arisaema, and 6-12 parts of common bletilla pseudobulb. According to the topical Chinese medicine preparation for treatment of mammary breast gland lobular hyperplasia, the production process is simple, the production cost is low, implementation is high, large-scale industrial production is easy, the Chinese medicine preparation prepared from the semen citri reticulatae, the thunberg fritillary bulb, the radix scrophulariae, the concha ostreae, the olibanum, the myrrh, the corydalis yanhusuo, the cinnamon, the bile arisaema, the common bletilla pseudobulb and the like in a composite mode has a significant effect on treatment of mammary breast gland lobular hyperplasia, the treatment effect is significant, and the side effect is small; meanwhile, use is convenient, and stability and the effect of drugs can be well ensured; and according to the physicochemical properties of the components contained in all medical compositions and research results of the pharmacological effects of components of all the medical compositions, the reasonable and stable preparation ratio is obtained, and significant economic and social benefits are achieved.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to an external Chinese medicinal preparation for treating breast lobular hyperplasia. Background technique [0002] Breast lobular hyperplasia is a common disease among young and middle-aged women. It is a non-inflammatory breast disease characterized by periodic breast lumps and distending pain. At present, it is believed that its pathogenesis is related to endocrine dysfunction. It is a common benign breast lesion caused by excessive estrogen levels and an imbalance in the ratio of progesterone due to ovarian dysfunction. Cell hyperplasia is the main pathological feature. The name of the disease is numerous and confusing, such as lobular hyperplasia of the breast, cystic mastopathy, cystic hyperplasia of the breast, fibrocystic disease, etc. The WHO classifies breast lesions as breast dysplasia. [0003] At this stage, for breast lobular hyperplasia, the method of an...

AI Technical Summary

Problems solved by technology

[0003] At this stage, for breast lobular hyperplasia, the method of antagonizing estrogen is mainly used. Representative drugs include tamoxifen, methyltestosterone, etc., but long-term use will reduce the sensitivity of the endometrium to estrogen, and it is easier to Adverse reactions occur; a kind of external Chinese medicine preparation for the treatment of breast lobular hyperplasia disclosed by the invention is a traditional Chinese medicine preparation, which has the effects of dispelling stagnation, reducing swelling, dispelling blood stasis and relieving pain, etc. Pharmacological studies have shown that it has obvious effects on breast acinus and duct hyperplasia. inhibition

Images